Lazard Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,218
Closed -$27K 2313
2022
Q2
$27K Buy
+6,218
New +$44.9K ﹤0.01% 2039

Other funds holding SRTA

Lazard Asset Management's SRTA Position: Q3 2022 in Review

Lazard Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2022, closing a stake of 6,218 shares — an estimated $27K sold.

Lazard Asset Management first reported a position in SRTA in Q2 2022 and held it in 1 quarter. The position peaked at $27K in Q2 2022. 99 funds tracked by Wall St. Rank hold SRTA as of Q3 2022.

  • Lazard Asset Management reported no remaining Strata Critical Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 6,218 Strata Critical Medical Inc shares in Q3 2022, an estimated $27K.
  • Lazard Asset Management first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 1 quarter.
  • Lazard Asset Management's Strata Critical Medical Inc position peaked at $27K in Q2 2022.
  • 99 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.